SS Innovations International (SSII) Total Liabilities (2016 - 2026)
SS Innovations International (SSII) reported Total Liabilities of $36.0 million for Q1 2026, up 57.29% on a YoY basis from $22.9 million in Q1 2025, and little changed sequentially from $36.0 million in Q4 2025.
SS Innovations International (SSII) Total Liabilities (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Total Liabilities data on file, last reported at $36.0 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 57.29% year-over-year to $36.0 million; the trailing twelve-month figure through Mar 2026 stood at $36.0 million (up 57.29% YoY), and the FY2025 full-year result was $36.0 million, up 24.47% from the prior year.
- Total Liabilities steadied at $36.0 million in Q1 2026, from $36.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $36.0 million in Q1 2026 to a low of $279336.0 in Q2 2022.
- A 5-year average of $17.6 million and a median of $18.5 million in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities sank 36.52% in 2022 and jumped 3950.22% in 2023, its largest moves.
- Tracing SSII's Total Liabilities over 5 years: stood at $9.7 million in 2022, then rose by 22.14% to $11.8 million in 2023, then jumped by 145.2% to $28.9 million in 2024, then climbed by 24.47% to $36.0 million in 2025, then gained by 0.04% to $36.0 million in 2026.
- Business Quant data shows SSII's Total Liabilities at $36.0 million in Q1 2026, $36.0 million in Q4 2025, and $29.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.68 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 18.55 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.17 Bn |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 36.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.02 Mn |
| Dec 31, 2025 | 36.01 Mn |
| Sep 30, 2025 | 29.93 Mn |
| Jun 30, 2025 | 27.95 Mn |
| Mar 31, 2025 | 22.90 Mn |
| Dec 31, 2024 | 28.93 Mn |
| Sep 30, 2024 | 25.33 Mn |
| Jun 30, 2024 | 20.89 Mn |
| Mar 31, 2024 | 18.45 Mn |
| Dec 31, 2023 | 11.80 Mn |
| Sep 30, 2023 | 11.79 Mn |
| Jun 30, 2023 | 11.31 Mn |
| Mar 31, 2023 | 5.47 Mn |
| Dec 31, 2022 | 9.66 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 279,336.00 |
| Mar 31, 2022 | 367,396.00 |
| Dec 31, 2021 | 428,607.00 |
| Sep 30, 2021 | 334,401.00 |
| Jun 30, 2021 | 440,038.00 |